Recent court documents have revealed that the maker of GranuFlo, Fresenius USA, Inc., is facing more than 300 lawsuits, and more are expected to be filed in the coming months. As the basis for the personal injury and wrongful death suits, plaintiffs allege that the manufacturer was fully aware of the risks that were associated with alkali dosing errors but did not properly warn medical centers or patients about the dangers of a possible heart attack after taking GranuFlo.
The court documents that have been filed by GranuFlo lawsuit attorneys in relation to the 300 suits involve plaintiffs who are dialysis patients or their survivors who have suffered injuries, such as cardiopulmonary arrest, resulting from dialysis treatment with Fresenius’ products. GranuFlo lawsuit attorneys are currently seeking damages for wrongful death and personal injuries that are related to consuming GranuFlo during dialysis.
According to the documents that have been filed by GranuFlo lawsuit attorneys, the product causes a rapidly unsafe elevation of bicarbonate in the bloodstream, and this can result in an increased risk or heart attack and death that is 6 to 8 times higher than it is with other products. In addition, the GranuFlo lawsuit attorneys make the further claim that the drug’s manufacturer knew about the dangers or should have known about the heightened risk of cardiopulmonary arrest. The lawyers also make note of a study that was conducted by Fresenius in which about 940 patients who were treated with GranuFlo suffered sudden cardiac death as a result of cardiopulmonary arrest. According to GranuFlo lawsuit attorneys, patients may suffer cardiac arrest while in the midst of dialysis or up to two full days later.GranuFlo is commonly used during dialysis, and it helps the body maintain bicarbonate levels. Essential for neutralizing the increase of stomach acid in a person’s blood stream, bicarbonate levels can also lead to cardiopulmonary arrest in patients who have encountered dosing problems. The issue for GranuFlo lawsuit attorneys is not just about the dosing errors because the company allegedly issued recommendations to healthcare workers at the facilities that it owns without providing this information to other caregivers and their patients. In addition, the Food and Drug Administration only learned about the latest recommendations from Fresenius when the agency was anonymously given a memo. As a result of this memo, the FDA announced a recall of GranuFlo and Naturalyte in March of 2012 because the formulations could be associated with a host of different adverse reactions.
If you have been injured as a result of taking GranuFlo to help you with dialysis, you may be able to file a personal injury suit that provides you with the ability to recover financial damages for your pain and suffering as well as any lost income or rehabilitative care. At the Attorney Group, we’re committed to helping you seek the compensation that you need to recover from your losses, and our affiliated GranuFlo lawsuit attorneys are waiting to discuss your case. We’re here to assist you throughout the entire process, and you can contact us at anytime to help you decide if you have a claim or even just answer any legal questions you may have. Because time is of the essence, it is imperative to contact GranuFlo lawsuit attorneys as soon as possible and start the filing process. If you have any questions about GranuFlo, contact Attorney Group today.